Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
16,7 ILa | -2,34% | -6,18% | -56,28% |
Omzet 2024 * | 14,36 mln. 5,4 mld. 13,48 mln. | Omzet 2025 * | 27,77 mln. 10,44 mld. 26,07 mln. | Marktkapitalisatie | 52,76 mln. 19,83 mld. 49,53 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -47 mln. -17,67 mld. -44,12 mln. | Nettowinst (verlies) 2025 * | -36 mln. -13,53 mld. -33,79 mln. | EV/omzet 2024 * | 3,67 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 1,9 x |
K/w-verhouding 2024 * |
-2,2
x | K/w-verhouding 2025 * |
-
| Werknemers | 79 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,64% |
Recentste transcriptie over BioLineRx Ltd.
1 dag | -2,34% | ||
1 week | -6,18% | ||
Lopende maand | -40,57% | ||
1 maand | -41,61% | ||
3 maanden | -52,82% | ||
6 maanden | -57,29% | ||
Lopend jaar | -56,28% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Philip Serlin
CEO | Chief Executive Officer | 62 | 24-05-09 |
Mali Zeevi
DFI | Director of Finance/CFO | 48 | 01-01-09 |
Irit Gliko-Kabir
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sandra Panem
BRD | Director/Board Member | 77 | 24-02-14 |
Michael Anghel
BRD | Director/Board Member | 85 | 01-09-10 |
Avraham Molcho
BRD | Director/Board Member | 66 | 01-01-10 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 16,7 | -2,34% | 1 098 013 |
17-04-24 | 17,1 | +0,59% | 2 295 728 |
16-04-24 | 17 | -5,56% | 2 308 134 |
15-04-24 | 18 | -0,55% | 1 007 013 |
14-04-24 | 18,1 | +1,69% | 1 301 451 |
uitgestelde koers TEL AVIV STOCK EXCHANGE, 18 april 2024 om 16:24 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-56,28% | 52,76 mln. | |
-3,10% | 102 mld. | |
+2,11% | 96,07 mld. | |
-1,80% | 21,66 mld. | |
-17,75% | 20,77 mld. | |
-6,91% | 18,53 mld. | |
-42,00% | 16,91 mld. | |
-28,19% | 13,79 mld. | |
+0,18% | 13,33 mld. | |
+19,90% | 10,94 mld. |